Identification of a class of potent USP25/28 inhibitors with broad-spectrum anti-cancer activity
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
|---|---|
| Enthalten in: |
Signal transduction and targeted therapy - 7(2022), 1 vom: 08. Dez., Seite 393 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Peng, Jin [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
EC 3.4.19.12 |
|---|
| Anmerkungen: |
Date Completed 15.12.2022 Date Revised 09.01.2023 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41392-022-01209-2 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM349940835 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM349940835 | ||
| 003 | DE-627 | ||
| 005 | 20231226043825.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41392-022-01209-2 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1166.xml |
| 035 | |a (DE-627)NLM349940835 | ||
| 035 | |a (NLM)36481755 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Peng, Jin |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Identification of a class of potent USP25/28 inhibitors with broad-spectrum anti-cancer activity |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.12.2022 | ||
| 500 | |a Date Revised 09.01.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a USP25 protein, human |2 NLM | |
| 650 | 7 | |a Ubiquitin Thiolesterase |2 NLM | |
| 650 | 7 | |a EC 3.4.19.12 |2 NLM | |
| 700 | 1 | |a Jiang, Kun |e verfasserin |4 aut | |
| 700 | 1 | |a Sun, Xiao |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Lingzhi |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Jiewei |e verfasserin |4 aut | |
| 700 | 1 | |a Xi, Xiaomei |e verfasserin |4 aut | |
| 700 | 1 | |a Tan, Xu |e verfasserin |4 aut | |
| 700 | 1 | |a Liang, Tingbo |e verfasserin |4 aut | |
| 700 | 1 | |a Tan, Changheng |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Pumin |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Signal transduction and targeted therapy |d 2016 |g 7(2022), 1 vom: 08. Dez., Seite 393 |w (DE-627)NLM257871861 |x 2059-3635 |7 nnns |
| 773 | 1 | 8 | |g volume:7 |g year:2022 |g number:1 |g day:08 |g month:12 |g pages:393 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41392-022-01209-2 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 7 |j 2022 |e 1 |b 08 |c 12 |h 393 | ||